US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYVERSA THERAPEUTICS INC

0.6190

+0.00911.49%

Post-market: 0.62000.0010+0.16%19:59 EDT

Volume:150.64K

Turnover:89.96K

Market Cap:2.24M

PE:-0.07

High:0.6300

Open:0.5900

Low:0.5860

Close:0.6099

Loading ...

Overview Company News Filings

BRIEF-Zyversa Therapeutics Announces Published Data Showing Inflammasome Asc Inhibitor IC 100 Decreases Microglial Inflammasome Activation

Zyversa Therapeutics Announces Published Data Showing Inflammasome Asc Inhibitor Ic 100 Decreases Microglial Inflammasome Activation and Alpha-Synuclein That Contribute to Neurodegeneration in Parkinson’s Disease

THOMSON REUTERS

ZyVersa Therapeutics Announces Published Data Showing Inflammasome ASC Inhibitor IC 100 Decreases Microglial Inflammasome Activation and Alpha-Synuclein That Contribute to Neurodegeneration in Parkinson’s Disease

BRIEF-ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative Research And Development Trends For Inflammasome Inhibitors, And Provides Update On Inflammasome ASC Inhibitor IC 100’S Development Status

Zyversa Therapeutics CEO Issues Shareholder Letter on Parasol Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (Fsgs)

THOMSON REUTERS

Zyversa Therapeutics: Initiating Small Phase 2a Proof-of-Concept Trial With Var 200 in First Half of 2025 in Patients With Dkd

THOMSON REUTERS

ZyVersa Therapeutics CEO Issues Shareholder Letter on PARASOL Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (FSGS)

ZyVersa Therapeutics files to sell 4.21M shares of common stock for holders

ZyVersa Therapeutics FY24 EPS $(8.48) Up From $(1,089.70) YoY

Press Release: ZyVersa Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

ZyVersa Therapeutics Highlights Data Published in the Journal of the American Heart Association Demonstrating Inflammasome Inhibition Attenuates Obesity-Associated Cardiomyopathy in Animal Model Study

ZyVersa Therapeutics prices 2.1M shares at 95c in private placement

Zyversa Therapeutics, Inc. Announces Pricing of $2.0 Million Private Placement Priced at the Market

THOMSON REUTERS

ZyVersa Therapeutics highlights data on NLRP3 inflammasome inhibition

BRIEF-Zyversa Therapeutics Files For Prospectus Related To Offer & Resale Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC Filing

OTC Markets Hosts Virtual Investor Presentation with Stephen Glover, CEO of ZyVersa Therapeutics, Inc., with Brad Sorensen, Senior Analyst at Zacks SCR

Zacks Small Cap Research

ZyVersa Therapeutics announces publication on ASC Inhibitor IC 100

Life Sciences Investor Forum: Presentations Now Available for Online Viewing

ZyVersa Therapeutics Q3 2024 GAAP EPS $(2.43) Beats $(3.70) Estimate

Zyversa Therapeutics - Qtrly Loss per Share $2.43

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ZVSA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZVSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZVSA\",,,,,undefined,":{"symbol":"ZVSA","market":"US","secType":"STK","nameCN":"ZYVERSA THERAPEUTICS INC","latestPrice":0.619,"timestamp":1746129600000,"preClose":0.6099,"halted":0,"volume":150642,"hourTrading":{"tag":"盘后","latestPrice":0.62,"preClose":0.619,"latestTime":"19:59 EDT","volume":15048,"amount":8682.0084,"timestamp":1746143962766},"delay":0,"floatShares":2502300,"shares":3619456,"eps":-8.480319,"marketStatus":"Closed","change":0.0091,"latestTime":"05-01 16:00:00 EDT","open":0.59,"high":0.63,"low":0.586,"amount":89956.4578038,"amplitude":0.072143,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-8.480319,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746172800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.6099,"preHourTrading":{"tag":"盘前","latestPrice":0.5798,"preClose":0.6099,"latestTime":"09:24 EDT","volume":15825,"amount":9371.177287499999,"timestamp":1746105860759},"postHourTrading":{"tag":"盘后","latestPrice":0.62,"preClose":0.619,"latestTime":"19:59 EDT","volume":15048,"amount":8682.0084,"timestamp":1746143962766},"volumeRatio":0.105461},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZVSA\",,,,,undefined,":{"symbol":"ZVSA","floatShares":2502300,"roa":"-26.74%","roe":"-96.10%","lyrEps":-8.480319,"volumeRatio":0.105461,"shares":3619456,"dividePrice":0,"high":0.63,"amplitude":0.072143,"preClose":0.6099,"low":0.586,"week52Low":0.5516,"pbRate":"0.26","week52High":6.6855,"institutionHeld":0,"latestPrice":0.619,"eps":-8.480319,"divideRate":0,"volume":150642,"delay":0,"ttmEps":-8.480319,"open":0.59,"prevYearClose":1.06,"prevWeekClose":0.701,"prevMonthClose":0.6099,"prevQuarterClose":0.6286,"fiveDayClose":0.7151,"twentyDayClose":0.5873,"sixtyDayClose":1.28},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZVSA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531739814","title":"BRIEF-Zyversa Therapeutics Announces Published Data Showing Inflammasome Asc Inhibitor IC 100 Decreases Microglial Inflammasome Activation","url":"https://stock-news.laohu8.com/highlight/detail?id=2531739814","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531739814?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:50","pubTimestamp":1745931028,"startTime":"0","endTime":"0","summary":"BRIEF-Zyversa Therapeutics Announces Published Data Showing Inflammasome Asc Inhibitor IC 100 Decreases Microglial Inflammasome Activation April 29 (Reuters) - Zyversa Therapeutics Inc ZVSA.O:ZYVERSA ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nTUA12JXSK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZVSA"],"gpt_icon":0},{"id":"2531873597","title":"Zyversa Therapeutics Announces Published Data Showing Inflammasome Asc Inhibitor Ic 100 Decreases Microglial Inflammasome Activation and Alpha-Synuclein That Contribute to Neurodegeneration in Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2531873597","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531873597?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:57","pubTimestamp":1745927820,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nTUA12JXSK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZVSA"],"gpt_icon":0},{"id":"2531801387","title":"ZyVersa Therapeutics Announces Published Data Showing Inflammasome ASC Inhibitor IC 100 Decreases Microglial Inflammasome Activation and Alpha-Synuclein That Contribute to Neurodegeneration in Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2531801387","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531801387?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:57","pubTimestamp":1745927820,"startTime":"0","endTime":"0","summary":"Study supported by the Michael J. Fox Foundation through a grant awarded to ZyVersa and leading inflammasome experts at University of Miami Miller School of Medicine who conducted the study.Parkinson’s Disease  affects over 10 million people globally and is driven by inflammation leading to progressive neurodegeneration resulting in impaired mobility, cognitive decline, and other neurological symptoms.WESTON, Fla., April 29, 2025  -- ZyVersa Therapeutics, Inc. , a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, announces newly published data supporting the potential of its Inflammasome ASC Inhibitor IC 100 to slow the progression of Parkinson’s disease.Published in npj Parkinson's Disease, a peer-reviewed journal from Nature, the study presents groundbreaking findings from researchers at the University of Miami Miller School of Medicine. The research demonstrates that IC 100 blocks microglial inflammas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zyversa-therapeutics-announces-published-data-115700776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ASC","BK4007","FSGS","PD","BK4144","LU1169589451.USD","BK4023","ZVSA","LENZ","BK4139","LU1169590202.USD"],"gpt_icon":0},{"id":"2529816929","title":"BRIEF-ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative Research And Development Trends For Inflammasome Inhibitors, And Provides Update On Inflammasome ASC Inhibitor IC 100’S Development Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2529816929","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529816929?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:26","pubTimestamp":1745497586,"startTime":"0","endTime":"0","summary":"BRIEF-ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative Research And Development Trends For Inflammasome Inhibitors, And Provides Update On Inflammasome ASC Inhibitor IC 100","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA836CC1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZVSA"],"gpt_icon":0},{"id":"2525896963","title":"Zyversa Therapeutics CEO Issues Shareholder Letter on Parasol Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (Fsgs)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525896963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525896963?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:57","pubTimestamp":1744113434,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM0TT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2525896957","title":"Zyversa Therapeutics: Initiating Small Phase 2a Proof-of-Concept Trial With Var 200 in First Half of 2025 in Patients With Dkd","url":"https://stock-news.laohu8.com/highlight/detail?id=2525896957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525896957?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:57","pubTimestamp":1744113434,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM0TT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2525894454","title":"ZyVersa Therapeutics CEO Issues Shareholder Letter on PARASOL Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (FSGS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525894454","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525894454?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:57","pubTimestamp":1744113420,"startTime":"0","endTime":"0","summary":"WESTON, Fla., April 08, 2025  -- ZyVersa Therapeutics, Inc. , a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who have unmet medical needs, announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, has issued a Shareholder Letter addressing the recent PARASOL recommendations expected to shorten drug development time and approval for rare kidney disease, FSGS. The full text of the letter follows.ZyVersa is developing Cholesterol Efflux MediatorVAR 200 for treatment of chronic kidney diseases, initially focusing on FSGS as the lead. Plans for indication expansion include treatments for Alport Syndrome and Diabetic Kidney Disease. The global drug market for kidney diseases was $18 Billion in 2024, with $30 Billion projected by 2034 .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zyversa-therapeutics-ceo-issues-shareholder-115700993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZVSA","BK4139","BK4007","LENZ","FSGS"],"gpt_icon":0},{"id":"2525753430","title":"ZyVersa Therapeutics files to sell 4.21M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2525753430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525753430?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:50","pubTimestamp":1743799808,"startTime":"0","endTime":"0","summary":"16:48 EDT ZyVersa Therapeutics (ZVSA) files to sell 4.21M shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-files-to-sell-4-21m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-files-to-sell-4-21m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","ZVSA","BK4139"],"gpt_icon":0},{"id":"2522370306","title":"ZyVersa Therapeutics FY24 EPS $(8.48) Up From $(1,089.70) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2522370306","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522370306?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:18","pubTimestamp":1743081512,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics FY24 EPS $(8.48) Up From $(1,089.70) YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44514150/zyversa-therapeutics-fy24-eps-8-48-up-from-1-089-70-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ZVSA"],"gpt_icon":0},{"id":"2522050543","title":"Press Release: ZyVersa Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522050543","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522050543?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:15","pubTimestamp":1743081300,"startTime":"0","endTime":"0","summary":"-- Phase 2a proof-of concept clinical trial for Cholesterol Efflux. Mediator VAR 200 in patients with diabetic kidney disease . -- Regulatory path for VAR 200's lead indication, focal segmental. glomerulosclerosis , expected to be shorter based on FDA's. alignment with data supporting proteinuria reduction as a clinical. WESTON, Fla., March 27, 2025  -- ZyVersa Therapeutics, Inc. , a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases with high unmet medical needs, reports financial results for full year ending December 31, 2024, and provides business update.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4585","03160","ZVSA","BK4139","TM","BK4555","BK4604","BK4588","FSGS","BK4099"],"gpt_icon":0},{"id":"2520670180","title":"ZyVersa Therapeutics Highlights Data Published in the Journal of the American Heart Association Demonstrating Inflammasome Inhibition Attenuates Obesity-Associated Cardiomyopathy in Animal Model Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2520670180","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520670180?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:57","pubTimestamp":1742299020,"startTime":"0","endTime":"0","summary":"In obesity-associated cardiomyopathy , heart muscle is structurally and functionally abnormal, impairing the ability to effectively pump blood. Five-year survival rate is less than 50%, with congestive heart failure and sudden cardiac death predominant causes of death.Data showed that NLRP3 inflammasome inhibition attenuated inflammation, heart muscle enlargement and fibrosis, and improved heart function.Data support the potential of ZyVersa’s Inflammasome ASC Inhibitor IC 100 as an effective treatment option for patients with obesity and its associated cardiovascular comorbidities.WESTON, Fla., March 18, 2025  -- ZyVersa Therapeutics, Inc. , a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, highlights newly published animal model data demonstrating that inflammasome inhibition attenuates obesity-associated cardiomyopathy, which has a 5-year survival rate <50%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zyversa-therapeutics-highlights-data-published-115700084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","ZVSA","AFG"],"gpt_icon":0},{"id":"2517202152","title":"ZyVersa Therapeutics prices 2.1M shares at 95c in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2517202152","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517202152?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:12","pubTimestamp":1741266744,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics (ZVSA) has entered into a securities purchase agreement with a single healthcare-focused U.S. institutional investor for the p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-prices-2-1m-shares-at-95c-in-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-prices-2-1m-shares-at-95c-in-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","ZVSA"],"gpt_icon":0},{"id":"2517154920","title":"Zyversa Therapeutics, Inc. Announces Pricing of $2.0 Million Private Placement Priced at the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154920","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154920?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266015,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP10R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2517919437","title":"ZyVersa Therapeutics highlights data on NLRP3 inflammasome inhibition","url":"https://stock-news.laohu8.com/highlight/detail?id=2517919437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517919437?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:55","pubTimestamp":1741179355,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics (ZVSA) highlights newly published data demonstrating cardioprotective effects and improvements in metabolic parameters with in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-highlights-data-on-nlrp3-inflammasome-inhibition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-highlights-data-on-nlrp3-inflammasome-inhibition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","ZVSA","BK4139"],"gpt_icon":0},{"id":"2493408477","title":"BRIEF-Zyversa Therapeutics Files For Prospectus Related To Offer & Resale Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2493408477","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493408477?lang=en_us&edition=fundamental","pubTime":"2024-12-21 06:12","pubTimestamp":1734732725,"startTime":"0","endTime":"0","summary":"BRIEF-Zyversa Therapeutics Files For Prospectus Related To Offer & Resale Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC FilingZyversa Therapeutics Inc ZVSA.O:ZYVERSA THERAPEUTICS: FILES FOR PROSPECTUS RELATED TO OFFER & RESALE OF UP TO 1.6 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDER - SEC FILINGSource text: [ID:n0001493152-24-051094]Further company coverage: ZVSA.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL1HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2485448993","title":"OTC Markets Hosts Virtual Investor Presentation with Stephen Glover, CEO of ZyVersa Therapeutics, Inc., with Brad Sorensen, Senior Analyst at Zacks SCR","url":"https://stock-news.laohu8.com/highlight/detail?id=2485448993","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485448993?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:32","pubTimestamp":1732192320,"startTime":"0","endTime":"0","summary":"Anthony Kraus: Hello, and welcome to Virtual Investor Conferences. My name is Anthony Kraus, and on behalf of OTC markets, as well as our co-host, Zacks Small Cap Research, we're very pleased you have joined us for our next live presentation from ZyVersa Therapeutics, Inc. Their session will be moderated by Brad Sorensen, senior Equity Research Analyst with Zacks Small Cap Research. Please note that you can submit questions for the presenter in the box to the left of the slides. You can also view the company's availability for one-on-one meetings through the Schedule Meetings tab found on the conference platform. At this point, I'm very pleased to welcome Stephen Glover, co-founder, chairman, CEO, and president of ZyVersa Therapeutics, Inc., which trades on the NASDAQ under the symbol ZVSA. Welcome, Stephen.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/otc-markets-hosts-virtual-investor-123200296.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZVSA","BK4209","SG","LENZ","BK4139"],"gpt_icon":0},{"id":"2484415115","title":"ZyVersa Therapeutics announces publication on ASC Inhibitor IC 100","url":"https://stock-news.laohu8.com/highlight/detail?id=2484415115","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484415115?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:05","pubTimestamp":1732107927,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics (ZVSA) announces newly published data demonstrating that stroke-related cardiovascular injury and dysfunction is induced by AI...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-announces-publication-on-asc-inhibitor-ic-100-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zyversa-therapeutics-announces-publication-on-asc-inhibitor-ic-100-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4144","ZVSA","BK4139","ASC"],"gpt_icon":0},{"id":"2483376412","title":"Life Sciences Investor Forum: Presentations Now Available for Online Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2483376412","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483376412?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:35","pubTimestamp":1731677700,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov. 15, 2024  -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor Forum, held November 14th are now available for online viewing.The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section.Select companies are accepting 1x1 management meeting requests through November 19th.Virtual Investor Conferences  is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/life-sciences-investor-forum-presentations-133500021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MBCOF","FET","CGTX","DRMAW","ZVSA","DRMA","NRBO","BK4179"],"gpt_icon":0},{"id":"2483687066","title":"ZyVersa Therapeutics Q3 2024 GAAP EPS $(2.43) Beats $(3.70) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483687066","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483687066?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:14","pubTimestamp":1731590063,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics Q3 2024 GAAP EPS $(2.43) Beats $(3.70) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41970762/zyversa-therapeutics-q3-2024-gaap-eps-2-43-beats-3-70-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVSA","LENZ"],"gpt_icon":0},{"id":"2483770028","title":"Zyversa Therapeutics - Qtrly Loss per Share $2.43","url":"https://stock-news.laohu8.com/highlight/detail?id=2483770028","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483770028?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:10","pubTimestamp":1731589800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA301QGL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZVSA"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZVSA\",params:#limit:5,,,undefined,":[{"date":"2025-03-27","symbol":"ZVSA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"Pre-Market","dateTimestamp":1743048000000,"actualEps":null},{"market":"US","date":"2024-11-14","symbol":"ZVSA","fiscalQuarterEnding":"2024/09","expectedEps":-5.8,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-2.43},{"market":"US","date":"2024-08-09","symbol":"ZVSA","fiscalQuarterEnding":"2024/06","expectedEps":-5.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":-3.31},{"market":"US","date":"2024-05-15","symbol":"ZVSA","fiscalQuarterEnding":"2024/03","expectedEps":-3.7,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"pre","actualEps":-4.53},{"market":"US","date":"2024-04-26","symbol":"ZVSA","defaultRemindTime":1714138200000,"type":"split","dateTimestamp":1714104000000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZVSA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZVSA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZVSA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZVSA","date":"2025-04-30","current":-0.257768,"percent":0.487742,"low":-21.281928,"twenty":-7.844246,"median":-0.193785,"eighty":-0.053166,"high":-0.009885,"avg":-2.700832,"sd":3.914699,"marketCap":2426483},"quantilePoints":[{"date":"2022-02-11","current":-7.527467,"twenty":-7.527467,"median":-7.527467,"eighty":-7.527467,"marketCap":95472110},{"date":"2022-02-18","current":-7.542751,"twenty":-7.542751,"median":-7.542751,"eighty":-7.527467,"marketCap":95665962},{"date":"2022-02-25","current":-7.542751,"twenty":-7.542751,"median":-7.542751,"eighty":-7.527467,"marketCap":95665962},{"date":"2022-03-04","current":-7.535109,"twenty":-7.542751,"median":-7.542751,"eighty":-7.535109,"marketCap":95569036},{"date":"2022-03-11","current":-7.550393,"twenty":-7.542751,"median":-7.542751,"eighty":-7.535109,"marketCap":95762888},{"date":"2022-03-18","current":-7.565677,"twenty":-7.550393,"median":-7.542751,"eighty":-7.535109,"marketCap":95956740},{"date":"2022-03-25","current":-7.603888,"twenty":-7.550393,"median":-7.542751,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-01","current":-7.603888,"twenty":-7.565677,"median":-7.550393,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-08","current":-7.603888,"twenty":-7.603888,"median":-7.550393,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-14","current":-7.603888,"twenty":-7.603888,"median":-7.550393,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-22","current":-7.852153,"twenty":-7.603888,"median":-7.558035,"eighty":-7.542751,"marketCap":99590164},{"date":"2022-04-29","current":-7.860061,"twenty":-7.603888,"median":-7.565677,"eighty":-7.542751,"marketCap":99690456},{"date":"2022-05-06","current":-7.867968,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99790748},{"date":"2022-05-13","current":-7.836338,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99389580},{"date":"2022-05-20","current":-7.875876,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99891041},{"date":"2022-05-27","current":-7.852153,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99590164},{"date":"2022-06-03","current":-7.875876,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99891041},{"date":"2022-06-10","current":-7.875876,"twenty":-7.867968,"median":-7.603888,"eighty":-7.547336,"marketCap":99891041},{"date":"2022-06-17","current":-7.836338,"twenty":-7.867968,"median":-7.603888,"eighty":-7.550393,"marketCap":99389580},{"date":"2022-06-24","current":-7.875876,"twenty":-7.867968,"median":-7.820523,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-07-01","current":-7.836338,"twenty":-7.867968,"median":-7.836338,"eighty":-7.550393,"marketCap":99389580},{"date":"2022-07-08","current":-7.860061,"twenty":-7.867968,"median":-7.836338,"eighty":-7.550393,"marketCap":99690456},{"date":"2022-07-15","current":-7.875876,"twenty":-7.867968,"median":-7.844246,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-07-22","current":-7.875876,"twenty":-7.874294,"median":-7.844246,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-07-29","current":-7.875876,"twenty":-7.875876,"median":-7.850967,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-08-05","current":-7.891691,"twenty":-7.875876,"median":-7.852153,"eighty":-7.55345,"marketCap":100091625},{"date":"2022-08-12","current":-10.347355,"twenty":-7.875876,"median":-7.852153,"eighty":-7.565677,"marketCap":100292210},{"date":"2022-08-19","current":-10.337007,"twenty":-7.875876,"median":-7.852153,"eighty":-7.565677,"marketCap":100191917},{"date":"2022-08-26","current":-10.337007,"twenty":-7.875876,"median":-7.852153,"eighty":-7.565677,"marketCap":100191917},{"date":"2022-09-02","current":-10.32666,"twenty":-7.875876,"median":-7.852153,"eighty":-7.573319,"marketCap":100091625},{"date":"2022-09-09","current":-10.347355,"twenty":-7.883783,"median":-7.860061,"eighty":-7.603888,"marketCap":100292210},{"date":"2022-09-16","current":-10.316312,"twenty":-7.891691,"median":-7.860061,"eighty":-7.603888,"marketCap":99991333},{"date":"2022-09-23","current":-10.357702,"twenty":-7.907506,"median":-7.860061,"eighty":-7.603888,"marketCap":100392502},{"date":"2022-09-30","current":-10.434782,"twenty":-10.316312,"median":-7.860061,"eighty":-7.603888,"marketCap":100191917},{"date":"2022-10-07","current":-10.445227,"twenty":-10.32666,"median":-7.860061,"eighty":-7.603888,"marketCap":100292210},{"date":"2022-10-14","current":-10.476563,"twenty":-10.32666,"median":-7.867968,"eighty":-7.603888,"marketCap":100593086},{"date":"2022-10-21","current":-10.497453,"twenty":-10.337007,"median":-7.867968,"eighty":-7.603888,"marketCap":100793671},{"date":"2022-10-28","current":-10.476563,"twenty":-10.337007,"median":-7.875876,"eighty":-7.603888,"marketCap":100593086},{"date":"2022-11-04","current":-10.507899,"twenty":-10.347355,"median":-7.875876,"eighty":-7.603888,"marketCap":100893963},{"date":"2022-11-11","current":-10.539234,"twenty":-10.357702,"median":-7.875876,"eighty":-7.603888,"marketCap":101194839},{"date":"2022-11-18","current":-10.586238,"twenty":-10.378397,"median":-7.875876,"eighty":-7.603888,"marketCap":101646154},{"date":"2022-11-25","current":-10.643686,"twenty":-10.434782,"median":-7.875876,"eighty":-7.603888,"marketCap":102197761},{"date":"2022-12-02","current":-10.654132,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":102298054},{"date":"2022-12-09","current":-10.121425,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":97183151},{"date":"2022-12-16","current":-2.562,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":29243788},{"date":"2022-12-23","current":-1.710652,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":19526132},{"date":"2022-12-30","current":-1.249174,"twenty":-10.453583,"median":-7.875876,"eighty":-7.603888,"marketCap":14258617},{"date":"2023-01-06","current":-1.281,"twenty":-10.441049,"median":-7.875876,"eighty":-7.580961,"marketCap":14621894},{"date":"2023-01-13","current":-2.752956,"twenty":-10.434782,"median":-7.875876,"eighty":-7.556507,"marketCap":31423450},{"date":"2023-01-20","current":-1.718609,"twenty":-10.434782,"median":-7.875876,"eighty":-7.550393,"marketCap":19616951},{"date":"2023-01-27","current":-1.670869,"twenty":-10.434782,"median":-7.875876,"eighty":-7.550393,"marketCap":19072036},{"date":"2023-02-03","current":-1.933435,"twenty":-10.434782,"median":-7.867968,"eighty":-7.542751,"marketCap":22069070},{"date":"2023-02-10","current":-1.607217,"twenty":-10.424337,"median":-7.867968,"eighty":-7.542751,"marketCap":18345482},{"date":"2023-02-17","current":-1.869782,"twenty":-10.381724,"median":-7.860061,"eighty":-7.536637,"marketCap":21342516},{"date":"2023-02-24","current":-1.702696,"twenty":-10.378397,"median":-7.860061,"eighty":-7.527467,"marketCap":19435313},{"date":"2023-03-03","current":-1.654956,"twenty":-10.357702,"median":-7.860061,"eighty":-4.265844,"marketCap":18890397},{"date":"2023-03-10","current":-1.670869,"twenty":-10.357702,"median":-7.860061,"eighty":-2.418782,"marketCap":19072036},{"date":"2023-03-17","current":-1.400348,"twenty":-10.357702,"median":-7.860061,"eighty":-2.060739,"marketCap":15984182},{"date":"2023-03-24","current":-1.734522,"twenty":-10.357702,"median":-7.852153,"eighty":-1.958179,"marketCap":19798589},{"date":"2023-03-31","current":-1.535609,"twenty":-10.357702,"median":-7.852153,"eighty":-1.869782,"marketCap":17528109},{"date":"2023-04-06","current":-1.400348,"twenty":-10.351494,"median":-7.852153,"eighty":-1.858643,"marketCap":15984182},{"date":"2023-04-14","current":-1.154538,"twenty":-10.347355,"median":-7.852153,"eighty":-1.802948,"marketCap":16305101},{"date":"2023-04-21","current":-1.141492,"twenty":-10.347355,"median":-7.852153,"eighty":-1.755336,"marketCap":16120863},{"date":"2023-04-28","current":-0.327576,"twenty":-10.347355,"median":-7.850967,"eighty":-1.734569,"marketCap":4626227},{"date":"2023-05-05","current":-0.37167,"twenty":-10.347355,"median":-7.844246,"eighty":-1.722141,"marketCap":5248953},{"date":"2023-05-12","current":-0.323359,"twenty":-10.347355,"median":-7.844246,"eighty":-1.702696,"marketCap":4566681},{"date":"2023-05-19","current":-0.244626,"twenty":-10.341146,"median":-7.836338,"eighty":-1.670869,"marketCap":3404726},{"date":"2023-05-26","current":-0.271366,"twenty":-10.337007,"median":-7.836338,"eighty":-1.65973,"marketCap":3776888},{"date":"2023-06-02","current":-0.595797,"twenty":-10.337007,"median":-7.82843,"eighty":-1.607217,"marketCap":8292357},{"date":"2023-06-09","current":-0.579813,"twenty":-10.337007,"median":-7.820523,"eighty":-1.591304,"marketCap":8069879},{"date":"2023-06-16","current":-0.561146,"twenty":-10.337007,"median":-7.603888,"eighty":-1.559478,"marketCap":7810081},{"date":"2023-06-23","current":-0.440415,"twenty":-10.337007,"median":-7.603888,"eighty":-1.529243,"marketCap":6129730},{"date":"2023-06-30","current":-0.430212,"twenty":-10.337007,"median":-7.603888,"eighty":-1.457635,"marketCap":5987729},{"date":"2023-07-07","current":-0.408107,"twenty":-10.332868,"median":-7.603888,"eighty":-1.400348,"marketCap":5680059},{"date":"2023-07-14","current":-0.425111,"twenty":-10.32666,"median":-7.603888,"eighty":-1.296913,"marketCap":5916728},{"date":"2023-07-21","current":-0.368996,"twenty":-10.32666,"median":-7.603888,"eighty":-1.261904,"marketCap":5135720},{"date":"2023-07-28","current":-0.313371,"twenty":-10.32666,"median":-7.603888,"eighty":-1.163669,"marketCap":4361521},{"date":"2023-08-04","current":-0.309309,"twenty":-10.32666,"median":-7.565677,"eighty":-1.141492,"marketCap":4304983},{"date":"2023-08-11","current":-0.307181,"twenty":-10.32666,"median":-7.558035,"eighty":-1.11801,"marketCap":4275368},{"date":"2023-08-18","current":-0.303699,"twenty":-10.32666,"median":-7.550393,"eighty":-1.058,"marketCap":4226907},{"date":"2023-08-25","current":-0.051589,"twenty":-10.32666,"median":-7.550393,"eighty":-0.57554,"marketCap":4665022},{"date":"2023-09-01","current":-0.048582,"twenty":-10.32666,"median":-7.550393,"eighty":-0.562665,"marketCap":4393153},{"date":"2023-09-08","current":-0.041989,"twenty":-10.32666,"median":-7.542751,"eighty":-0.558863,"marketCap":3796895},{"date":"2023-09-15","current":-0.060169,"twenty":-10.320451,"median":-7.542751,"eighty":-0.517114,"marketCap":5440931},{"date":"2023-09-22","current":-0.052281,"twenty":-10.316312,"median":-7.542751,"eighty":-0.441231,"marketCap":4727605},{"date":"2023-09-29","current":-0.060153,"twenty":-10.303896,"median":-7.542751,"eighty":-0.431743,"marketCap":5439425},{"date":"2023-10-06","current":-0.062896,"twenty":-10.295618,"median":-7.542751,"eighty":-0.424227,"marketCap":5687462},{"date":"2023-10-13","current":-0.06304,"twenty":-10.253773,"median":-7.535109,"eighty":-0.407903,"marketCap":5700517},{"date":"2023-10-20","current":-0.061644,"twenty":-10.163206,"median":-7.527467,"eighty":-0.38615,"marketCap":5574322},{"date":"2023-10-27","current":-0.055581,"twenty":-10.142315,"median":-7.523646,"eighty":-0.376992,"marketCap":5026028},{"date":"2023-11-03","current":-0.046534,"twenty":-8.35029,"median":-4.265844,"eighty":-0.362186,"marketCap":4207939},{"date":"2023-11-10","current":-0.035803,"twenty":-7.907506,"median":-2.657478,"eighty":-0.333478,"marketCap":3237545},{"date":"2023-11-17","current":-0.036701,"twenty":-7.907506,"median":-2.17213,"eighty":-0.328592,"marketCap":3289764},{"date":"2023-11-24","current":-0.040004,"twenty":-7.907506,"median":-2.068696,"eighty":-0.324245,"marketCap":3585846},{"date":"2023-12-01","current":-0.031557,"twenty":-7.898017,"median":-2.024935,"eighty":-0.316333,"marketCap":2828641},{"date":"2023-12-08","current":-0.015952,"twenty":-7.891691,"median":-1.958179,"eighty":-0.309502,"marketCap":1429861},{"date":"2023-12-15","current":-0.01023,"twenty":-7.891691,"median":-1.901609,"eighty":-0.307413,"marketCap":916976},{"date":"2023-12-22","current":-0.048692,"twenty":-7.886946,"median":-1.861826,"eighty":-0.30211,"marketCap":4364571},{"date":"2023-12-29","current":-0.055512,"twenty":-7.883783,"median":-1.857848,"eighty":-0.290163,"marketCap":4975946},{"date":"2024-01-05","current":-0.052962,"twenty":-7.883783,"median":-1.853869,"eighty":-0.285597,"marketCap":4747336},{"date":"2024-01-12","current":-0.047393,"twenty":-7.883783,"median":-1.802152,"eighty":-0.251536,"marketCap":4248168},{"date":"2024-01-19","current":-0.034922,"twenty":-7.879039,"median":-1.770326,"eighty":-0.072424,"marketCap":3130284},{"date":"2024-01-26","current":-0.038707,"twenty":-7.875876,"median":-1.750753,"eighty":-0.065177,"marketCap":3469529},{"date":"2024-02-02","current":-0.034243,"twenty":-7.875876,"median":-1.742518,"eighty":-0.062982,"marketCap":3069461},{"date":"2024-02-09","current":-0.03412,"twenty":-7.875876,"median":-1.734522,"eighty":-0.061606,"marketCap":3058450},{"date":"2024-02-16","current":-0.03374,"twenty":-7.875876,"median":-1.721553,"eighty":-0.060163,"marketCap":3024368},{"date":"2024-02-23","current":-0.036285,"twenty":-7.875876,"median":-1.710652,"eighty":-0.059241,"marketCap":3252454},{"date":"2024-03-01","current":-0.064345,"twenty":-7.875876,"median":-1.702696,"eighty":-0.0586,"marketCap":5767693},{"date":"2024-03-08","current":-0.080782,"twenty":-7.875876,"median":-1.674847,"eighty":-0.059241,"marketCap":7241014},{"date":"2024-03-15","current":-0.06769,"twenty":-7.875876,"median":-1.670869,"eighty":-0.060042,"marketCap":6067487},{"date":"2024-03-22","current":-0.069477,"twenty":-7.875876,"median":-1.658934,"eighty":-0.060153,"marketCap":6227737},{"date":"2024-03-28","current":-0.060072,"twenty":-7.875876,"median":-1.619152,"eighty":-0.060088,"marketCap":5904958},{"date":"2024-04-05","current":-0.057206,"twenty":-7.875876,"median":-1.599261,"eighty":-0.058057,"marketCap":5623190},{"date":"2024-04-12","current":-0.057947,"twenty":-7.875876,"median":-1.591304,"eighty":-0.057773,"marketCap":5696100},{"date":"2024-04-19","current":-0.048367,"twenty":-7.875876,"median":-1.559478,"eighty":-0.05663,"marketCap":4754345},{"date":"2024-04-26","current":-0.046937,"twenty":-7.875876,"median":-1.533619,"eighty":-0.055531,"marketCap":4613841},{"date":"2024-05-03","current":-0.044349,"twenty":-7.875876,"median":-1.495826,"eighty":-0.054896,"marketCap":4359415},{"date":"2024-05-10","current":-0.040795,"twenty":-7.875876,"median":-1.424376,"eighty":-0.05319,"marketCap":4010054},{"date":"2024-05-17","current":-0.037826,"twenty":-7.875876,"median":-1.400348,"eighty":-0.051973,"marketCap":3691072},{"date":"2024-05-24","current":-0.03339,"twenty":-7.875876,"median":-1.308848,"eighty":-0.051476,"marketCap":3258245},{"date":"2024-05-31","current":-0.031755,"twenty":-7.875876,"median":-1.292934,"eighty":-0.050906,"marketCap":3098678},{"date":"2024-06-07","current":-0.03697,"twenty":-7.875876,"median":-1.281,"eighty":-0.049989,"marketCap":3607530},{"date":"2024-06-14","current":-0.041742,"twenty":-7.875876,"median":-1.23334,"eighty":-0.049025,"marketCap":4073207},{"date":"2024-06-21","current":-0.041325,"twenty":-7.875876,"median":-1.167583,"eighty":-0.048602,"marketCap":4032547},{"date":"2024-06-28","current":-0.030973,"twenty":-7.875876,"median":-1.16106,"eighty":-0.048367,"marketCap":3022323},{"date":"2024-07-05","current":-0.030887,"twenty":-7.875876,"median":-1.141492,"eighty":-0.047431,"marketCap":3013974},{"date":"2024-07-12","current":-0.043208,"twenty":-7.875876,"median":-1.134969,"eighty":-0.046921,"marketCap":4216224},{"date":"2024-07-15","current":-0.041924,"twenty":-7.875876,"median":-1.128446,"eighty":-0.046855,"marketCap":4090990},{"date":"2024-08-02","current":-0.029261,"twenty":-7.875876,"median":-1.128446,"eighty":-0.046715,"marketCap":2855344},{"date":"2024-08-09","current":-0.025753,"twenty":-7.875876,"median":-1.108878,"eighty":-0.04506,"marketCap":2513036},{"date":"2024-08-16","current":-0.142372,"twenty":-7.875876,"median":-1.069741,"eighty":-0.045348,"marketCap":3108171},{"date":"2024-08-23","current":-0.142372,"twenty":-7.874294,"median":-0.579813,"eighty":-0.045816,"marketCap":3108171},{"date":"2024-08-30","current":-0.130115,"twenty":-7.867968,"median":-0.574291,"eighty":-0.046563,"marketCap":2840580},{"date":"2024-09-06","current":-0.132,"twenty":-7.867968,"median":-0.567606,"eighty":-0.04668,"marketCap":2881748},{"date":"2024-09-13","current":-0.105129,"twenty":-7.867968,"median":-0.561146,"eighty":-0.046855,"marketCap":2295107},{"date":"2024-09-20","current":-0.107014,"twenty":-7.867968,"median":-0.545154,"eighty":-0.046937,"marketCap":2336274},{"date":"2024-09-27","current":-0.108429,"twenty":-7.867968,"median":-0.494999,"eighty":-0.04713,"marketCap":2367150},{"date":"2024-10-04","current":-0.111201,"twenty":-7.860061,"median":-0.442115,"eighty":-0.047393,"marketCap":2427682},{"date":"2024-10-11","current":-0.11563,"twenty":-7.860061,"median":-0.437694,"eighty":-0.04744,"marketCap":2524360},{"date":"2024-10-18","current":-0.111201,"twenty":-7.860061,"median":-0.431488,"eighty":-0.047955,"marketCap":2427682},{"date":"2024-10-25","current":-0.101853,"twenty":-7.860061,"median":-0.426981,"eighty":-0.048002,"marketCap":2223585},{"date":"2024-10-31","current":-0.098959,"twenty":-7.860061,"median":-0.4229,"eighty":-0.048294,"marketCap":2160422},{"date":"2024-11-08","current":-0.07479,"twenty":-7.860061,"median":-0.412358,"eighty":-0.048539,"marketCap":1632777},{"date":"2024-11-15","current":-0.055601,"twenty":-7.860061,"median":-0.407596,"eighty":-0.048609,"marketCap":1213841},{"date":"2024-11-22","current":-0.057411,"twenty":-7.860061,"median":-0.384846,"eighty":-0.048677,"marketCap":1224583},{"date":"2024-11-29","current":-0.118021,"twenty":-7.860061,"median":-0.371269,"eighty":-0.048708,"marketCap":2517426},{"date":"2024-12-06","current":-0.113252,"twenty":-7.860061,"median":-0.366321,"eighty":-0.048948,"marketCap":2415688},{"date":"2024-12-13","current":-0.118692,"twenty":-7.860061,"median":-0.339908,"eighty":-0.049263,"marketCap":2531726},{"date":"2024-12-20","current":-0.136276,"twenty":-7.860061,"median":-0.332663,"eighty":-0.049654,"marketCap":2906796},{"date":"2024-12-27","current":-0.135177,"twenty":-7.856898,"median":-0.328846,"eighty":-0.049901,"marketCap":2883354},{"date":"2025-01-03","current":-0.119791,"twenty":-7.852153,"median":-0.327576,"eighty":-0.050145,"marketCap":2555168},{"date":"2025-01-10","current":-0.129682,"twenty":-7.852153,"median":-0.324836,"eighty":-0.050769,"marketCap":2766145},{"date":"2025-01-17","current":-0.148365,"twenty":-7.852153,"median":-0.320528,"eighty":-0.050891,"marketCap":3164657},{"date":"2025-01-24","current":-0.165949,"twenty":-7.852153,"median":-0.316323,"eighty":-0.050891,"marketCap":3539728},{"date":"2025-01-31","current":-0.151662,"twenty":-7.852153,"median":-0.310469,"eighty":-0.050903,"marketCap":3234983},{"date":"2025-02-07","current":-0.135726,"twenty":-7.852153,"median":-0.309502,"eighty":-0.051217,"marketCap":2895075},{"date":"2025-02-14","current":-0.14287,"twenty":-7.852153,"median":-0.307568,"eighty":-0.05144,"marketCap":3047448},{"date":"2025-02-21","current":-0.134078,"twenty":-7.852153,"median":-0.304393,"eighty":-0.051476,"marketCap":2859913},{"date":"2025-02-28","current":-0.128583,"twenty":-7.852153,"median":-0.301891,"eighty":-0.051476,"marketCap":2742703},{"date":"2025-03-07","current":-0.097811,"twenty":-7.852153,"median":-0.288309,"eighty":-0.051544,"marketCap":2086329},{"date":"2025-03-14","current":-0.08803,"twenty":-7.852153,"median":-0.285224,"eighty":-0.051753,"marketCap":1877696},{"date":"2025-03-21","current":-0.07704,"twenty":-7.852153,"median":-0.271366,"eighty":-0.051882,"marketCap":1643277},{"date":"2025-03-28","current":-0.076919,"twenty":-7.851441,"median":-0.246413,"eighty":-0.052127,"marketCap":1640699},{"date":"2025-04-04","current":-0.166148,"twenty":-7.850967,"median":-0.166148,"eighty":-0.052638,"marketCap":1564028},{"date":"2025-04-11","current":-0.210427,"twenty":-7.846934,"median":-0.172378,"eighty":-0.052911,"marketCap":1980845},{"date":"2025-04-17","current":-0.194413,"twenty":-7.844246,"median":-0.202243,"eighty":-0.052945,"marketCap":1830092},{"date":"2025-04-25","current":-0.195095,"twenty":-7.844246,"median":-0.193158,"eighty":-0.053044,"marketCap":1836513},{"date":"2025-04-30","current":-0.257768,"twenty":-7.844246,"median":-0.193785,"eighty":-0.053166,"marketCap":2426483}],"updateTime":1746152076600}}}